Literature DB >> 3400763

Progression of visual defects in ischemic optic neuropathy.

L B Kline1.   

Abstract

Six patients with nonarteritic ischemic optic neuropathy experienced worsening of visual acuity and field loss during the six-week period after onset (range, three to six weeks), without apparent ophthalmoscopic changes. Thereafter, visual function remained unchanged. Various medications were used, but none prevented deterioration of visual function. Although not a widely recognized phenomenon, progression of visual deficit occurred in these patients in the early weeks after onset of ischemic optic neuropathy.

Entities:  

Mesh:

Year:  1988        PMID: 3400763     DOI: 10.1016/0002-9394(88)90835-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial.

Authors:  Barbara Wilhelm; Holger Lüdtke; Helmut Wilhelm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-08       Impact factor: 3.117

2.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

3.  Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

4.  The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis).

Authors:  Anthony C Arnold; Roberta M S Costa; Oana M Dumitrascu
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

5.  The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial.

Authors:  Mohammad Pakravan; Nasrin Sanjari; Hamed Esfandiari; Parastou Pakravan; Mehdi Yaseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-10       Impact factor: 3.117

6.  Analysis of Retinal Nerve Fibre Thickening in Progressive and Non-progressive Non-arteritic Anterior Ischaemic Optic Neuropathy Using Optical Coherence Tomography.

Authors:  Hirooki Hashimoto; Masayuki Hata; Satoshi Kashii; Akio Oishi; Kenji Suda; Eri Nakano; Manabu Miyata; Akitaka Tsujikawa
Journal:  Neuroophthalmology       Date:  2020-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.